Lyka Labs Ltd banner

Lyka Labs Ltd
NSE:LYKALABS

Watchlist Manager
Lyka Labs Ltd Logo
Lyka Labs Ltd
NSE:LYKALABS
Watchlist
Price: 54.82 INR 6.28%
Market Cap: ₹2B

Profitability Summary

Lyka Labs Ltd's profitability score is 41/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

41/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

41/100
Profitability
Score
41/100
Profitability
Score

Margins

Earnings Waterfall
Lyka Labs Ltd

Margins Comparison
Lyka Labs Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Lyka Labs Ltd
NSE:LYKALABS
2B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
867.4B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
571.4B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
257.8B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
220.3B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
228.9B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
283.3B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
240.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
155.3B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
119.5B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Lyka Labs Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Lyka Labs Ltd
NSE:LYKALABS
2B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
867.4B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
571.4B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
257.8B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
220.3B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
228.9B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
283.3B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
240.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
155.3B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
119.5B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Lyka Labs Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett